Featured Posts
The National Multi-Omics Accelerator: How Broad Clinical Labs Provides Inclusive Access to Translational Science and Technology For three decades, the genomics field has refined the science and methodology of sequencing....Read More
From Bench to Clinical Scale: Broad Clinical Labs’ Approach to Scaling a Custom Assay Translating a high-performing custom benchtop assay into a reliable, clinical-grade operation at scale is technically challenging....Read More
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in...Read More
Short-Read vs. Long-Read WGS: Which is Right for Your Next Project? Key Takeaways: Your sequencing strategy decision impacts downstream analysis and research outcomes Short-read sequencing enables cost-efficient analysis of...Read More
At Broad Clinical Labs (BCL), the expertise behind our operations is powered by dedicated professionals who ensure that our science is accurate, reliable, and ready to make a real impact....Read More
BOSTON, MA — October 15, 2025 — Broad Clinical Labs (BCL), in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, today announced official recognition by Guinness World Records for...Read More
At Broad Clinical Labs (BCL), the journey from an idea to a working product often involves people who bridge science, technology, and customer needs. One of those people is Matthew...Read More
At Broad Clinical Labs (BCL), our people are at the core of everything we do. Their expertise and dedication are what make it possible to advance cutting-edge science and deliver...Read More
Mass General Brigham Launches Genetic Test to Predict Risk Across Eight Cardiovascular Conditions Boston, MA – September 3,2025 — In a step forward for genomic-driven preventive medicine, Mass General Brigham...Read More
At Broad Clinical Labs (BCL), science moves with collaboration. Carrie, our Director of Cancer Genomics, has spent over two decades at the forefront of genomics, helping shape landmark discoveries and...Read More
The National Multi-Omics Accelerator: How Broad Clinical Labs Provides Inclusive Access to Translational Science and Technology For three decades, the genomics field has refined the science and methodology of...
From Bench to Clinical Scale: Broad Clinical Labs’ Approach to Scaling a Custom Assay Translating a high-performing custom benchtop assay into a reliable, clinical-grade operation at scale is technically...
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available...
Advancing patient care starts with making complex science usable in the real world. Yueyao Gao, Senior Computational Scientist in the Translational Analysis Group (TAG) at Broad Clinical Labs, works...
Short-Read vs. Long-Read WGS: Which is Right for Your Next Project? Key Takeaways: Your sequencing strategy decision impacts downstream analysis and research outcomes Short-read sequencing enables cost-efficient analysis...
At Broad Clinical Labs, our people are at the heart of the groundbreaking science that drives discovery and improves patient care. In this Q&A, we sit down with Andrew...